COVID-19 Research Paper Volume 12, Issue 9 pp 7639—7651
Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
Figure 2. The pneumonia related interleukin cytokines variation trend after SARS-CoV treatment 12h, 24h and 48h respectively. (A) IL-1α; (B) IL-1β; (C) IL-6; (D) IL-7; (E) IL-10; (F) IL-23α.